10 Stocks That Stole the Show Today

8. Moderna, Inc. (NASDAQ:MRNA)

Moderna Inc. grew its share prices by 6.15 percent on Monday to finish at $26.39 apiece as investor sentiment was buoyed by the Department of Health and Human Services’ pledge not to upend the US vaccine system.

Additionally, investors are in a wait-and-see mode for a planned “massive framework” for the US vaccine industry.

Details have yet to be publicized, but the plan is being overseen by the Food and Drug Administration.

Investors were hopeful that any initiative could benefit both end-consumers and vaccine makers such as Moderna, Inc. (NASDAQ:MRNA), which found success with its own COVID-19 shots.

In the first quarter of the year, Moderna, Inc. (NASDAQ:MRNA) narrowed its net loss by 17.4 percent to $971 million from $1.17 billion in the same period last year. Revenues declined by 35 percent to $108 million from $167 million in the same period last year due to lower vaccination rates, coupled with the continued normalization of COVID into a seasonal commercial market.

Looking ahead, Moderna, Inc. (NASDAQ:MRNA) is targeting to book revenues between $1.5 billion and $2.5 billion.